← SynDRA
DEXPROPRANOLOL
SynDRA canonical compound SYN0000537 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADRB2 | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLC6A4
- HTR2B
- KCNH2
- ADRB1
- CYP2D6
- SIGMAR1
- ACHE
- NR2E1
- NPY2R
- NPY1R
- NFKB1
- MPHOSPH8
- MMP9
- MMP1
- MC5R
- MC4R
- MAPK3
- MC3R
- OPRD1
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- HTR6
- HTR2C
- HTR2A
- HSD17B10
- NR3C1
- OPRM1
- OPRK1
- HRH1
- USP1
- UGT1A8
- UGT1A10
- TSHR
- TRPV1
- TP53
- THPO
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2D6
- SCN1A
- SCN2A
- SCN3A
- SLC10A1
Cross-references
Synonyms
- Propranolol, (r)-
- BRD-K92830582
- propranolol-(R)
- (+)-Propranolol
- D-Propranolol
- 2R-Propranolol
- (R)-(+)-propranolol
- R-(+)-Propranolol
- Dextropropranolol
- Dexpropranololum
- R (+)-Propanolol
- Despropranolo
- (+)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
- (2R)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
- PG6KY07UD7
- CHEBI:8736
- DTXCID1025304
- (2R)-3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
- RefChem:585865
- (R)-Propranolol
- R(+)-propranolol
- NCGC00016429-05
- 2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, (+)-
- Despropranolo [DCIT]
- MLS001333595
- Dexpropranolol [INN:BAN]
- (R)-Propranolol (hydrochloride)
- Dexpropranololum [INN-Latin]
- CAS-5051-22-9
- SMR000875288
- EINECS 225-749-2
- UNII-PG6KY07UD7
- (2R)-1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
- RNP
- MFCD00066275
- d-(+)-Propranolol
- Tocris-0624
- Tocris-0835
- (+)-(r)-propranolol
Look up DEXPROPRANOLOL in the interactive SynDRA portal →